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Annotation.The article deals with current issues of chronic mesenteric ischemia 
related to clinical manifestations and timely diagnosis. 
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Introduction 
Chronic mesenteric ischemia (CMI) is a group of diseases caused by one or more 
abdominal aorta unpaired branches impairment. There are two major groups of CMI 
causes. The first one includes diseases of the arteries (atherosclerosis, vascular 
abnormalities, Takayasu’sarteriitis).The second group consists of extravasal causes 
(median arcuate ligament syndrome, etc.) [2]. Atherosclerotic vascular lesions occur 
in more than 90% of cases [1], thereforeCMI is more often diagnosed in people with 
cardiovascular diseases [3]. In young patients, the symptoms of CMI may be related to 
systemic vasculitis or connective tissue dysplasia [3]. 
Intestinal ischemia occurs in approximately 0.1% of hospital admissions and 
1.0% of cases among those who applied to the clinic of “acute abdomen”. CMI is 
dangerous due to life-threatening complications, including abdominal infarctions, 
perforations of hollow organs, and the development of sepsis [1]. Deaths due to CMI 
occur in 24-94%of cases [1]. 
Risk factors of CMI include smoking, dyslipidemia, hypertension and diabetes 
mellitus. Women are affected 3-4 times more often than men [3]. 
The exact prevalence of CMI is unknown. However, the number of patients who 
underwent revascularization is constantly increasing. As the population is aging and 
incidence of cardiovascular diseases is high, the number of patients with CMI is 
expected to increase in the near future [4]. 
Purpose: to study the main clinical manifestations of CMI and to identify 
problematic issues of the diagnosis. 
Material and methods of research 
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A number of papers describe the clinical manifestations of CMI and their 
variability. CMI symptoms may resemble those of other gastrointestinal diseases. It 
can cause diarrhea or constipation, nausea, vomiting,etc. The main manifestations 
called the classical triad are post-prandial abdominal pain, weight loss, and 
abdominalbruit. Abdominal pain often occurs 30-60 minutes after a meal, and it causes 
a fear of eating [1]. However, these symptoms are also non-specific and occur only in 
16-22% of cases [1,2].  
According to earlier reports, the subjects with CMI were more likely to be 
underweight.Currently, CMI is also diagnosed in overweight or obese patients [5]. 
Abdominalaorta unpaired branches impairment may also occur 
asymptomatically due to a network of collaterals development [4]. Thus, in the study 
of patients younger than 65 years, asymptomatic stenosis of the celiac trunk and/or 
upper mesenteric artery was diagnosed in 3% of cases, and in 18% of cases in patients 
older than 65 years [6].  
CMI clinical patterns diversity leads to late diagnosis [1]. During the 
examination, the identified symptoms are often considered to be related to chronic 
inflammatory processes and prescribed anti-inflammatory treatment turns to be 
ineffective. Therefore, in cases of ineffective treatment, a targeted diagnostic search 
for CMI is necessary. 
Laboratorytestsare reported to be non-specific for CMI [3, 4]. Anemia, 
leukopenia, electrolyte disturbances, and hypoalbuminemia are possible [1]. Further 
research is needed to identify potential sensitive CMI biomarkers.  
The slow course of the disease, the absence of specific symptoms, and the 
developed vascular collaterals network make the diagnosis very difficult, especially at 
early stages. Duplex ultrasonography (US), computed tomography (CT), magnetic 
resonance (MR), and angiography can be used as diagnostic methods. 
USisconsideredas a screening method [1].Using this method, it is possible to detect 
stenosis of the celiac trunk and the upper mesenteric artery in at least 70% of cases [4]. 
However, USis an operator-dependent method, and the evaluation of vessels may be 
hindered by previously installed stents. If CMI is suspected based on the results of US, 
CT angiography is required. With MR angiography, the lower mesenteric artery and 
smaller branches are less visualized. When CT is not possible, for example, due to 
kidney failure, allergy to contrast agents, MR angiography may be performed as an 
alternative[4]. 
It is also possible to detect signs of mucosal ischemia during endoscopic 
examinations (fibrogastroduodenoscopy, fibrocolonoscopy) with biopsy. 
Methods of open (OR) and endovascular revascularization (ER) of affected 
vessels are used as treatment [1]. Revascularization in patients with CMI results in 
relieving symptoms, improving quality of life, and restoring normal body weight [4]. 
For many years, open revascularization has been the method of choice [4]. Outcomes 
after the revascularization is worse in patients with excessive body mass [5]. After open 
revascularization, restenosis is less likely to develop, and there is a longer relief of 
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symptoms [1]. Endovascular interventions lead to a decrease in the duration of 
hospitalization and a lower mortality rate [1]. 
Study results and discussion 
In the absence of specific symptoms of CMI, a consensus of specialists (a 
vascular surgeon, a gastroenterologist, and a radiologist) is needed. The diagnosis is 
based on clinical manifestations, visualization and, if possible, assessment of signs of 
mucosal ischemia [4]. Development of an algorithm for early detection of CMI is 
urgently required. 
Conclusions: 
1. The main clinical manifestations of CMI are postprandial abdominal pain, 
weight loss, and abdominal bruit. 
2. The variability of symptoms leads to late diagnosis. 
3. Duplex ultrasonography is a screening method for CMI diagnostics. 
4. Development of an algorithm for early detection of CMI is required. 
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